Net sales |
2,456.9 |
2,333.2 |
2,549.4 |
Cost of sales |
1,421.2 |
1,414.7 |
1,596.7 |
Gross profit |
1,035.7 |
918.5 |
952.7 |
Operating expenses: |
Selling, technical, general and administrative |
628.8 |
596.8 |
578.6 |
Research and development |
63.0 |
68.1 |
48.8 |
Goodwill impairment |
- |
80.0 |
- |
Total operating expenses |
691.8 |
744.9 |
627.4 |
Operating profit |
343.9 |
173.6 |
325.3 |
Other (expense) income: |
Interest expense, net |
(46.3) |
(49.3) |
(51.2) |
Foreign exchange gain (loss) |
25.1 |
7.9 |
(5.0) |
Other income (expense), net |
(25.0) |
(3.1) |
2.9 |
Total other expense |
(56.2) |
(44.5) |
(53.3) |
Income (loss) before income taxes and non-controlling interests |
287.7 |
129.1 |
272.0 |
Income tax (expense) benefit |
(44.8) |
(13.0) |
(85.8) |
Net loss from continuing operations |
242.9 |
116.1 |
186.2 |
Income (loss) from discontinued operations, net of tax |
1.6 |
2.1 |
1.8 |
Net income (loss) |
244.5 |
118.2 |
188.0 |
Net loss attributable to non-controlling interests |
(0.3) |
(0.1) |
(0.8) |
Net income (loss) attributable to common stockholders |
244.2 |
118.1 |
187.2 |
|
Earnings (loss) per share |
Basic from continuing operations |
$1.00 |
$0.48 |
$0.75 |
Basic from discontinued operations |
$0.01 |
$0.01 |
$0.01 |
Basic attributable to common stockholders |
$1.01 |
$0.49 |
$0.76 |
|
Diluted from continuing operations |
$1.00 |
$0.48 |
$0.75 |
Diluted from discontinued operations |
$0.01 |
$0.01 |
$0.01 |
Diluted attributable to common stockholders |
$1.01 |
$0.49 |
$0.76 |
|
Weighted average common shares outstanding |
|
|
|
Basic |
242.1 |
241.4 |
245.1 |
Diluted |
242.6 |
245.8 |
247.9 |